학술논문

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia
Document Type
article
Source
Expert Review of Hematology. 16(sup1)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Clinical Research
Genetics
Hematology
Health and social care services research
8.1 Organisation and delivery of services
Good Health and Well Being
Adult
Humans
Child
United States
Hemophilia A
Delivery of Health Care
Medicine
Research
Community
hemophilia
inherited bleeding disorders
National Hemophilia Foundation
patient-centered
research
Cardiorespiratory Medicine and Haematology
Other Medical and Health Sciences
Cardiovascular medicine and haematology
Language
Abstract
BackgroundDecades of research have transformed hemophilia from severely limiting children's lives to a manageable disorder compatible with a full, active life, for many in high-income countries. The direction of future research will determine whether exciting developments truly advance health equity for all people with hemophilia (PWH). National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive inclusive all-stakeholder consultations to identify the priorities of people with inherited bleeding disorders and those who care for them.Research design and methodsWorking group (WG) 1 of the NHF State of the Science Research Summit distilled the community-identified priorities for hemophilia A and B into concrete research questions and scored their feasibility, impact, and risk.ResultsWG1 defined 63 top priority research questions concerning arthropathy/pain/bone health, inhibitors, diagnostics, gene therapy, the pediatric to adult transition of care, disparities faced by the community, and cardiovascular disease. This research has the potential to empower PWH to thrive despite lifelong comorbidities and achieve new standards of wellbeing, including psychosocial.ConclusionsCollaborative research and care delivery will be key to capitalizing on current and horizon treatments and harnessing technical advances to improve diagnostics and testing, to advance health equity for all PWH.